Humana (HUM) is trading down at $401.54 (-1.23%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Cantor Fitzgerald reiterates Humana stock rating at Neutral
Cantor Fitzgerald reiterates Humana stock rating at Neutral
Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?
Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?
Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October.
Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October.
Wolfe Research raises Humana stock price target to $450 on margin outlook
Wolfe Research raises Humana stock price target to $450 on margin outlook
Humana names Shantanu Nundy as chief medical officer
Humana names Shantanu Nundy as chief medical officer
Do Wall Street Analysts Like Humana Stock?
Do Wall Street Analysts Like Humana Stock?
Glenmark’s U.S. unit settles Humana antitrust case for $15.3 mln
Glenmark’s U.S. unit settles Humana antitrust case for $15.3 mln
Humana appoints James Holland to lead Medicaid business
Humana appoints James Holland to lead Medicaid business
Morgan Stanley upgrades Humana stock rating on 2028 margin confidence
Morgan Stanley upgrades Humana stock rating on 2028 margin confidence